ArticleAACE endocrinology and diabetes
Axis-Specific Peripartum Management for Radiation-Induced Panhypopituitarism With Arginine Vasopressin Deficiency: A Case Report.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: We report the perinatal course and practical, axis-specific management of a 34-year-old woman with panhypopituitarism and arginine vasopressin deficiency (AVP-D) consequent to cranial irradiation and ifosfamide, cisplatin, and etoposide chemotherapy for a germinoma who conceived via in vitro fertilization. Case Report: Care was organized by endocrine axis with coordinated obstetric collaboration. Subcutaneous growth hormone was discontinued upon pregnancy confirmation. Central hypothyroidism was managed using free thyroxine targets with trimester-appropriate oral levothyroxine dose adjustments. Secondary adrenal insufficiency was addressed with oral hydrocortisone and a predefined intrapartum stress-dose intravenous hydrocortisone plan. AVP-D was managed by continuing oral desmopressin with symptom-guided monitoring. Labor was electively induced at term, and the peripartum course was uncomplicated. Maternal and umbilical cord endocrine profiles at delivery were documented to contextualize axis physiology. The newborn had reassuring adaptation and normal early pediatric assessments. Discussion: This case illustrates that a pragmatic, axis-wise strategy centered on free thyroxine-guided thyroid replacement, explicit glucocorticoid stress coverage, and disciplined AVP-D monitoring can be safely implemented in collaboration with reproductive medicine and obstetrics after cranial irradiation and ifosfamide, cisplatin, and etoposide chemotherapy. Conclusion: A reproducible, axis-specific pathway may support safe pregnancy and delivery in women with complex pituitary sequelae, provided that monitoring plans and intrapartum stress-dose coverage are defined in advance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.